Year None202420232022202120202019201820172016 Date Latest Press Release May 30, 2018 Eiger BioPharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference May 24, 2018 Eiger BioPharmaceuticals Prices Previously Announced Public Offering of Common Stock May 23, 2018 Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock May 16, 2018 Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF) May 11, 2018 Eiger BioPharmaceuticals Reports First Quarter 2018 Financial Results April 17, 2018 Eiger Announces Sub-Analysis of Phase 2 Results Demonstrating High Response Rates to "All-Oral" Lonafarnib-Ritonavir Regimen in Low Viral Load HDV-Infected Patients at The International Liver Congress™ 2018 April 2, 2018 Eiger BioPharmaceuticals to Participate in Conferences in April March 26, 2018 Eiger Announces First Patient Dosed in Phase 2 PREVENT Study of Exendin 9-39 in Patients Suffering from Post-Bariatric Hypoglycemia March 21, 2018 Eiger BioPharmaceuticals Announces Positive Guidance Following FDA Meeting on Hepatitis Delta Virus Registration Program March 12, 2018 Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pagination First page « first Previous page ‹ previous … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page next › Last page last »